Our website uses cookies. By continuing to browse our site you are agreeing to our Cookie Policy.
Back To Top
In The News

Moderna partners with Swiss firm Lonza to produce potential coronavirus vaccine

May 1, 2020
Moderna, the Cambridge drug company whose experimental vaccine for the novel coronavirus was first in the United States to make it to clinical trials, has partnered with Swiss drug maker Lonza to manufacture up to 1 billion doses a year of the potential vaccine ― should it be approved by regulators ― the companies announced Friday. Read the full article By Jeremy C. Fox, Globe Correspondent on www.bostonglobe.com

Related Stories

In The News

Moderna shares jump after U.S. ups funding for coronavirus vaccine by $472 million

July 27, 2020
Read full article by Berkeley Lovelace Jr. and Will Feuer
Read More
In The News

Massachusetts scientists scramble to meet anticipated demand for Covid drug

July 3, 2020
NECI's Jenn Azar & Phil Braun discuss the need for automation.  Read Full Article By Allison DeAngelis, Life Sciences Reporter of the Boston Business Journal
Read More
In The News

Moderna to start final testing stage of coronavirus vaccine in July

June 11, 2020
Read full article by David L. Ryan of the Boston Globe
Read More